Area of research
Orthopedics and Sports Medicine · Molecular Biology
Research interest
Research interests include Bone health and osteoporosis research, Bone Metabolism and Diseases, Diabetes Treatment and Management, and Hippo pathway signaling and YAP/TAZ.
IRS-1 targets TAZ to inhibit adipogenesis of rat bone marrow mesenchymal stem cells through PI3K-Akt and MEK-ERK pathways
Liraglutide Inhibits the Apoptosis of MC3T3-E1 Cells Induced by Serum Deprivation through cAMP/PKA/β-Catenin and PI3K/AKT/GSK3β Signaling Pathways.
Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin
Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients
Associations between fat distribution and volumetric bone mineral density in Chinese adults
IGF1 promotes osteogenic differentiation of mesenchymal stem cells derived from rat bone marrow by increasing TAZ expression